What’s Happening With MDMA-Assisted Therapy for PTSD?
This course examines MDMA-assisted therapy for PTSD, including the substance’s history, current clinical research, and safety considerations in controlled therapeutic settings. It also outlines key contraindications and major studies shaping the evidence base.
Course Overview
This course provides an overview of MDMA as a potential treatment for post-traumatic stress disorder (PTSD). It traces MDMA’s history from early psychiatric use to recreational adoption and renewed clinical interest. The content focuses on the current research landscape, including work led by MAPS and findings on safety and efficacy when MDMA is used under professional guidance in controlled settings. It also reviews important safety considerations and contraindications discussed in the source material. The course is relevant for clinicians, therapists, and other mental health professionals interested in emerging PTSD treatments and the evidence supporting MDMA-assisted therapy.
Who is this for?
Clinicians, therapists, and other mental health professionals interested in MDMA-assisted therapy and PTSD treatment research.
About the Provider
Psychedelic-assisted therapy training arm co-founded by Beckley Waves and guided by Amanda Feilding, drawing on the Beckley Foundation's pioneering research. Offers cohort-based and self-managed courses for licensed mental health professionals in ketamine-, psilocybin-, and MDMA-assisted therapy, and published the first open-source Psychedelic-Assisted Therapy Learning Framework.
View Beckley Academy profileCourse Details
- PriceFree
- Lifecycle statusNo New Dates
- SkillsIntegrationPsychotherapyPsilocybin TherapyMDMA-Assisted TherapyUnderstanding the history of MDMA in psychiatryInterpreting clinical research on MDMA-assisted therapyIdentifying safety considerations and contraindicationsReviewing evidence for PTSD treatment approaches
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesCertificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
FDA On MDMA-Assisted Psychotherapy
This page discusses the FDA's rejection of MDMA-assisted psychotherapy and summarizes the rationale given for further research. It also reviews MDMA's history, reported therapeutic uses, and MAPS' response to the decision.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).
MAPS International MDMA-assisted Therapy Training Program
A collaboration between MAPS and the Clinical Psychedelic Lab at Monash University, this training program prepares mental healthcare professionals to support MDMA-assisted psychotherapy for PTSD. It combines online learning with a week-long in-person residential intensive and is limited to 65 trainees.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-12).